Experiences and challenges of African traditional medicine: lessons from COVID-19 pandemic.
Mutombo, PN
Kasilo, OMJ
James, PB
Wardle, J
Kunle, O
Katerere, D
Wambebe, C
Matsabisa, MG
Rahmatullah, M
Nikiema, J-B
Mukankubito, I
Sheridan, R
Sanogo, R
Nissapatorn, V
Sivakorn, C
Tripathy, S
Goyal, R
Dhobi, M
- Publisher:
- BMJ
- Publication Type:
- Journal Article
- Citation:
- BMJ Glob Health, 2023, 8, (8), pp. e010813
- Issue Date:
- 2023-08
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Mutombo, PN | |
dc.contributor.author | Kasilo, OMJ | |
dc.contributor.author | James, PB | |
dc.contributor.author |
Wardle, J https://orcid.org/0000-0001-8813-3542 |
|
dc.contributor.author | Kunle, O | |
dc.contributor.author | Katerere, D | |
dc.contributor.author | Wambebe, C | |
dc.contributor.author | Matsabisa, MG | |
dc.contributor.author | Rahmatullah, M | |
dc.contributor.author | Nikiema, J-B | |
dc.contributor.author | Mukankubito, I | |
dc.contributor.author | Sheridan, R | |
dc.contributor.author | Sanogo, R | |
dc.contributor.author | Nissapatorn, V | |
dc.contributor.author | Sivakorn, C | |
dc.contributor.author | Tripathy, S | |
dc.contributor.author | Goyal, R | |
dc.contributor.author | Dhobi, M | |
dc.date.accessioned | 2023-09-19T02:42:10Z | |
dc.date.available | 2023-04-24 | |
dc.date.available | 2023-09-19T02:42:10Z | |
dc.date.issued | 2023-08 | |
dc.identifier.citation | BMJ Glob Health, 2023, 8, (8), pp. e010813 | |
dc.identifier.issn | 2059-7908 | |
dc.identifier.issn | 2059-7908 | |
dc.identifier.uri | http://hdl.handle.net/10453/172195 | |
dc.description.abstract | Management of COVID-19 in Africa is challenging due to limited resources, including the high cost of vaccines, diagnostics, medical devices and routine pharmaceuticals. These challenges, in addition to wide acceptability, have resulted in increased use of herbal medicines based on African traditional medicines (ATMs) by patients in Africa. This is in spite of the often-significant gaps in evidence regarding these traditional medicines as to their efficacy and safety for COVID-19. African scientists, with some support from their governments, and guidance from WHO and other bodies, are addressing this evidence gap, developing and testing herbal medicines based on ATMs to manage mild-to-moderate cases of COVID-19. Such efforts need further support to meet public health needs. | |
dc.format | ||
dc.language | eng | |
dc.publisher | BMJ | |
dc.relation.ispartof | BMJ Glob Health | |
dc.relation.isbasedon | 10.1136/bmjgh-2022-010813 | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights | © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | |
dc.subject.classification | 4203 Health services and systems | |
dc.subject.classification | 4206 Public health | |
dc.subject.mesh | Humans | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Medicine, African Traditional | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Africa | |
dc.subject.mesh | Plant Extracts | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Plant Extracts | |
dc.subject.mesh | Medicine, African Traditional | |
dc.subject.mesh | Africa | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Medicine, African Traditional | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Africa | |
dc.subject.mesh | Plant Extracts | |
dc.title | Experiences and challenges of African traditional medicine: lessons from COVID-19 pandemic. | |
dc.type | Journal Article | |
utslib.citation.volume | 8 | |
utslib.location.activity | England | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHSP - Health Services and Practice | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2023-09-19T02:42:09Z | |
pubs.issue | 8 | |
pubs.publication-status | Published | |
pubs.volume | 8 | |
utslib.citation.issue | 8 |
Abstract:
Management of COVID-19 in Africa is challenging due to limited resources, including the high cost of vaccines, diagnostics, medical devices and routine pharmaceuticals. These challenges, in addition to wide acceptability, have resulted in increased use of herbal medicines based on African traditional medicines (ATMs) by patients in Africa. This is in spite of the often-significant gaps in evidence regarding these traditional medicines as to their efficacy and safety for COVID-19. African scientists, with some support from their governments, and guidance from WHO and other bodies, are addressing this evidence gap, developing and testing herbal medicines based on ATMs to manage mild-to-moderate cases of COVID-19. Such efforts need further support to meet public health needs.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph